Literature DB >> 4313252

Antigenic characterization of parainfluenza 4A and 4B by the hemagglutination-inhibition test and distribution of HI antibody in human sera.

G E Killgore, W R Dowdle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4313252     DOI： 10.1093/oxfordjournals.aje.a121141

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  10 in total

1.  Human parainfluenza virus 4 outbreak and the role of diagnostic tests.

Authors:  Susanna K P Lau; Wing-Kin To; Philomena W T Tse; Alex K H Chan; Patrick C Y Woo; Hoi-Wah Tsoi; Annie F Y Leung; Kenneth S M Li; Paul K S Chan; Wilina W L Lim; Raymond W H Yung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Physicochemical and serological characteristics of respiratory virus fluorescein-isothiocyanate conjugates for fluorescent-antibody diagnosis.

Authors:  H C Lyerla; J C Hierholzer
Journal:  J Clin Microbiol       Date:  1975-05       Impact factor: 5.948

Review 3.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

4.  Epidemiology and clinical presentation of the four human parainfluenza virus types.

Authors:  Wen-Kuan Liu; Qian Liu; De-Hui Chen; Huan-Xi Liang; Xiao-Kai Chen; Wen-Bo Huang; Sheng Qin; Zi-Feng Yang; Rong Zhou
Journal:  BMC Infect Dis       Date:  2013-01-23       Impact factor: 3.090

5.  The potential influence of human parainfluenza viruses detected during hospitalization among critically ill patients in Kuwait, 2013-2015.

Authors:  Sahar Essa; Haya Al-Tawalah; Sarah AlShamali; Widad Al-Nakib
Journal:  Virol J       Date:  2017-02-03       Impact factor: 4.099

6.  Studies of an outbreak of acute hepatitis A: II. Antibody changes to cytomegalovirus and herpersvirus.

Authors:  G M Baer; P A Yager
Journal:  J Med Virol       Date:  1977       Impact factor: 2.327

7.  Human parainfluenza type 4 infections, Canada.

Authors:  Marie-Louise Vachon; Natasha Dionne; Eric Leblanc; Danielle Moisan; Michel G Bergeron; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

Review 8.  Prophylaxis, therapy and prevention of viral respiratory infections.

Authors:  Dimitris A Kafetzis
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

9.  Viral pneumonia in children.

Authors:  Kelly J Henrickson
Journal:  Semin Pediatr Infect Dis       Date:  2006-06-03

Review 10.  Viral respiratory illnesses.

Authors:  L J Anderson; P A Patriarca; J C Hierholzer; G R Noble
Journal:  Med Clin North Am       Date:  1983-09       Impact factor: 5.456
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.